Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

BACKGROUND: Kisspeptins and their G-protein coupled receptor, GPR54 are required for GnRH release and have been associated with anti-metastatic tumour cell behaviour in model systems. The latter might suggest that their overexpression would be associated with a better prognosis in cancer. However, k...

Descripción completa

Detalles Bibliográficos
Autores principales: Prentice, Leah M, Klausen, Christian, Kalloger, Steve, Köbel, Martin, McKinney, Steven, Santos, Jennifer L, Kenney, Challayne, Mehl, Erika, Gilks, C Blake, Leung, Peter, Swenerton, Ken, Huntsman, David G, Aparicio, Samuel AJ
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200658/
https://www.ncbi.nlm.nih.gov/pubmed/18005407
http://dx.doi.org/10.1186/1741-7015-5-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200658/
https://www.ncbi.nlm.nih.gov/pubmed/18005407
http://dx.doi.org/10.1186/1741-7015-5-33

Ejemplares similares